The Subcommittee on Commerce, Manufacturing, and Trade, chaired by Rep. Lee Terry (R-NE), has scheduled a hearing for Tuesday, April 8, 2014, at 10:00 a.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled “Trolling for a Solution: Ending Abusive Patent Demand Letters.” Witnesses to be announced.
A Win for Pediatric Care, House Approves Bipartisan Children’s Hospital Graduate Medical Education Support Reauthorization ActApril 1, 2014 | Press Release
House Action Boosts Committee’s Record of Success in the Public Health Arena - Legislation Aimed to Help Train Pediatric Providers
The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), has scheduled a hearing for Tuesday, April 8, 2014, at 10:15 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled “Examining the Implementation of the Tobacco Control Act.” Witnesses to be announced.
The Committee on Energy and Commerce has scheduled a markup on Thursday, April 3, 2014, at 4:00 p.m. in room 2123 of the Rayburn House Office Building to consider H.R. 1281, “The Newborn Screening Saves Lives Reauthorization Act,” H.R. 3548, “The Improving Trauma Care Act,” H.R. 4080, “The Trauma Systems and Regionalization of Emergency Care Reauthorization Act,” and H.R. 1528, “The Veterinary Medicine Mobility Act.”
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) and Communications and Technology Subcommittee Chairman Greg Walden (R-OR) today continued the process of seeking public input as part of the review leading to an update of the Communications Act.
The Subcommittee on Health, chaired by Rep. Joe Pitts (R-PA), has scheduled a hearing for Monday, April 7, 2014, at 3:00 p.m. in room 2123 of the Rayburn House Office Building. The hearing is entitled “Improving Predictability and Transparency in DEA and FDA Regulation.” Witnesses to be announced. Subcommittee members will review three bills: H.R. 4299, the Improving Regulatory Transparency for New Medical Therapies Act, H.R. 4069, the Ensuring Patient Access and Effective Drug Enforcement Act, and H.R. 4250, the Sunscreen Innovation Act.